Allan H Smith

Title: The Innovative Contributions of Allan H. Smith

Introduction

Allan H. Smith, an inventive mind based in Zion, IL, has made significant contributions to the fields of drug stabilization and cancer immunoassays. With a total of four patents to his name, he continues to push the boundaries of scientific innovation.

Latest Patents

Among his recent inventions are two noteworthy patents. The first, "Stabilized standards and calibrators containing rapamycin," focuses on an in vitro aqueous composition comprising the drug rapamycin or tacrolimus, aimed at enhancing stability. This innovation utilizes a binding protein, FKBP, to maintain the drug's stability in an aqueous matrix. The second patent, "Immunoassays for prostate specific antigen," introduces a new methodology in cancer immunoassays, presenting a complex that could serve as a calibrator in PSA testing. Furthermore, it outlines a process for fractionating antibodies against PSA into those that bind masked epitopes and those that do not.

Career Highlights

Allan is affiliated with Abbott Laboratories Corporation, a leading global healthcare company that emphasizes innovation in human health. His role there allows him to collaborate on groundbreaking research and enhance medical diagnostics.

Collaborations

Throughout his career, Allan has worked alongside esteemed colleagues, including Barry Lee Dowell and Carol A. King. Their collaborative efforts have undoubtedly contributed to the depth and impact of his innovative work in the medical field.

Conclusion

With his inventive spirit and commitment to improving healthcare technologies, Allan H. Smith exemplifies the role of an innovator. His recent patents illustrate a significant advancement in drug stability and cancer detection, showcasing his ongoing contributions to the scientific community and beyond.